COMPOSITIONS PHARMACEUTIQUES ET REGIMES POSOLOGIQUES DESTINES A UNE UTILISATION CLINIQUE D'ANTICORPS ANTI-ANTIGENE 2 DE CELLULES DENDRITIQUES DU SANG

• 收藏
• 分享

专利权人:

BIOGEN MA INC.

发明人:

KREBS, MARK R. H.,DAI, DAVID,SULE, SHANTANU,RABAH, DANIA,MARTIN, DAVID

申请号：

CA3022116

公开号：

CA3022116A1

申请日:

2017.04.27

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

Formulations and dosage regimens of anti-Blood Dendritic Cell Antigen 2 (BDCA2) antibodies are provided. These formulations and dosage regimens find use in the treatment of BDCA2 -associated disorders such as systematic lupus erythematosus, cutaneous lupus eiythernatosus, and discoid lupus erythematosus, and cytokine release syndrome.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/